Ya-Wen Chen

Dr. Ya-Wen Chen

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
FBFenghua Bian
Fenghua Bian
YLYing-Wei Lan
Ying-Wei Lan
SZShuyang Zhao
Shuyang Zhao
Zicheng DengZicheng Deng
Zicheng Deng
SSSamriddhi Shukla
Samriddhi Shukla
TKTanya V Kalin
Tanya V Kalin
Pulmonary fibrosis results from dysregulated lung repair and involves multiple cell types. The role of endothelial cells (EC) in lung fibrosis is poorly understood. Using single cell RNA-sequencing we identified endothelial transcription factors involved in lung fibrogenesis, including FOXF1, SMAD6, ETV6 and LEF1. Focusing on FOXF1, we found that FOXF1 is decreased in EC within human idiopathic pulmonary fibrosis (IPF) and mouse bleomycin-injured lungs. Endothelial-specific Foxf1 inhibition in mice increased collagen depositions, promoted lung inflammation, and impaired R-Ras signaling. In vitro, FOXF1-deficient EC increased proliferation, invasion and activation of human lung fibroblasts, and stimulated macrophage migration by secreting IL-6, TNFα, CCL2 and CXCL1. FOXF1 inhibited TNFα and CCL2 through direct transcriptional activation of Rras gene promoter. Transgenic overexpression or endothelial-specific nanoparticle delivery of Foxf1 cDNA decreased pulmonary fibrosis in bleomycin-injured mice. Nanoparticle delivery of FOXF1 cDNA can be considered for future therapies in IPF.

10 August 2021 in Protein & Cell
Verified
Journal Article
Open access
PDF file
ATAbhimanyu Thakur
Abhimanyu Thakur
XKXiaoshan Ke
Xiaoshan Ke
YCYa-Wen Chen
Ya-Wen Chen
PMPedram Motallebnejad
Pedram Motallebnejad
Kui ZhangKui Zhang
Kui Zhang
HCHuanhuan Joyce Chen
Huanhuan Joyce Chen
Extracellular vesicles (EVs) are tiny biological nanovesicles ranging from approximately 30–1000 nm in diameter that are released into the extracellular matrix of most cell types and in biofluids. The classification of EVs includes exosomes, microvesicles, and apoptotic bodies, dependent on various factors such as size, markers, and biogenesis pathways. The transition of EV relevance from that of being assumed as a trash bag to be a key player in critical physiological and pathological conditions has been revolutionary in many ways. EVs have been recently revealed to play a crucial role in stem cell biology and cancer progression via intercellular communication, contributing to organ development and the progression of cancer. This review focuses on the significant research progress made so far in the role of the crosstalk between EVs and stem cells and their niche, and cellular communication among different germ layers in developmental biology. In addition, it discusses the role of EVs in cancer progression and their application as therapeutic agents or drug delivery vehicles. All such discoveries have been facilitated by tremendous technological advancements in EV-associated research, especially the microfluidics systems. Their pros and cons in the context of characterization of EVs are also extensively discussed in this review. This review also deliberates the role of EVs in normal cell processes and disease conditions, and their application as a diagnostic and therapeutic tool. Finally, we propose future perspectives for EV-related research in stem cell and cancer biology.
1

10 May 2023 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
ILIvana Matkovic Leko
Ivana Matkovic Leko
RSRemy T. Schneider
Remy T. Schneider
TTTania A. Thimraj
Tania A. Thimraj
NSNadine Schrode
Nadine Schrode
DBDaniel Beitler
Daniel Beitler
HSHans-Willem Snoeck
Hans-Willem Snoeck

3 November 2020 in WIREs Developmental Biology
Verified
Journal Article
Closed access
PDF file
LTLu Tian
Lu Tian
JGJinghui Gao
Jinghui Gao
IGIrving M. Garcia
Irving M. Garcia
HCHuanhuan Joyce Chen
Huanhuan Joyce Chen
ACAlessandra Castaldi
Alessandra Castaldi
YCYa-Wen Chen
Ya-Wen Chen

6 December 2024 in ACS Applied Polymer Materials
Verified
Journal Article
Closed access
XLXiaohan Li
Xiaohan Li
JHJiateng Huang
Jiateng Huang
YCYa-Wen Chen
Ya-Wen Chen
FZFeiyu Zhu
Feiyu Zhu
YWYepeng Wang
Yepeng Wang
Yakai FengYakai Feng
Yakai Feng

15 December 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
WDWen Du
Wen Du
JWJunqiang Wang
Junqiang Wang
TKTaiyi Kuo
Taiyi Kuo
LWLiheng Wang
Liheng Wang
WMWendy M. McKimpson
Wendy M. McKimpson
DADomenico Accili
Domenico Accili
As a highly regenerative organ, the intestine is a promising source for cellular reprogramming for replacing lost pancreatic β cells in diabetes. Gut enterochromaffin cells can be converted to insulin-producing cells by forkhead box O1 (FoxO1) ablation, but their numbers are limited. In this study, we report that insulin-immunoreactive cells with Paneth/goblet cell features are present in human fetal intestine. Accordingly, lineage-tracing experiments show that, upon genetic or pharmacologic FoxO1 ablation, the Paneth/goblet lineage can also undergo conversion to the insulin lineage. We designed a screening platform in gut organoids to accurately quantitate β-like cell reprogramming and fine-tune a combination treatment to increase the efficiency of the conversion process in mice and human adult intestinal organoids. We identified a triple blockade of FOXO1, Notch, and TGF-β that, when tested in insulin-deficient streptozotocin (STZ) or NOD diabetic animals, resulted in near normalization of glucose levels, associated with the generation of intestinal insulin-producing cells. The findings illustrate a therapeutic approach for replacing insulin treatment in diabetes.